Brief: Cdt Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
23/03/2026 12:36
CDT Equity Inc CDT.O: CDT IDENTIFIES RARE DISEASE OPPORTUNITIES THROUGH SARBORG SIGNATURE ANALYSIS, ADVANCING OUT-LICENSING STRATEGY Source text: ID:nGNX1S5BZx Further company coverage: CDT.O
Recent news on CDT Equity
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: CDT Equity - Enters Securities Purchase Agreement With Sarborg Investors On July 30, 2026 - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM